Embracing the Digital Revolution: Driving Innovation and Compliance in Pharma and Life Sciences

Scigeniq COO Wagner Moi was a keynote speaker at September's Innopharma Conference in Brazil. His talk,?AI: Beyond the Hype: Harnessing the Power of AI in Pharma Operations in the Near Term, spoke to pharmaceutical sector professionals and digital innovation developers.

Here's a short summary of his talk:

A digital revolution is underway, and professionals in the pharmaceutical and life sciences sectors are expected to engage actively. These highly regulated industries are primed for innovations that enhance business strategy and success.

One of the primary challenges is maintaining compliance with current Good Manufacturing Practices (GMP). Achieving and proving compliance requires strict quality control across the enterprise, from patient and customer experience to supplier quality management systems.

This demands managing vast amounts of data from every part of the value chain, which presents challenges. Integrating large datasets from various sources can make it difficult to generate the insights needed for informed business decisions. This is where AI can help.

To fully leverage AI, machine learning, and IoT, a digitized quality management system is essential. Other critical elements of a digital strategy include cloud storage, data capture technologies for manufacturing, and networked devices.

Research supports this approach. For instance, IQVIA found that organizations with higher levels of quality maturity—those that align people, processes, and technology—see improved compliance and lower costs.

By embracing the digital revolution, pharmaceutical and life sciences companies can unlock numerous opportunities. With strategic leadership, they can ensure that any digital solution implemented supports data integration and incorporates cutting-edge technologies.

The Benefits of Automated Asset Management for Pharma Companies

In pharma companies, an Asset Management System (AMS) is designed to oversee the lifecycle of assets, including laboratory instruments, manufacturing equipment, and even IT infrastructure, from acquisition through maintenance to eventual decommissioning.

But it's about more than managing assets. It’s a strategic investment ensuring operational resilience, regulatory compliance, and sustained quality. By integrating asset management with broader quality management functions, pharma companies can achieve a more cohesive and proactive approach to maintaining standards across their operations, ultimately driving better outcomes in a highly regulated industry.

Find out more.

Simplifying ANVISA Compliance with a Regulatory Management System

Navigating the complex regulatory environment is a constant challenge in every country. Between evolving standards, stringent documentation requirements, and the need for timely submissions, keeping up can overwhelm even the most efficient teams. Nowhere is this more true than in Brazil.

Find out why and how a Regulatory Management System can help. Read the blog.

Upcoming Event - CPHI December 10-12th

CPHI - December 10-12, find us at Booth 3, C5. Drop by to chat or get a demo of one of our solutions. If you'd like to set up a meeting, reach out, and we'll schedule a time.

About Scigeniq

We are deeply committed to helping customers leverage world-class software solutions to drive dramatic improvements in quality, regulatory, and content-management processes. Check out our full suite of quality, training, document management, and regulatory solutions to automate and optimize end-to-end processes and deliver maximum impact.

With decades of experience with some of the largest and best-known pharma companies in the Middle East and Africa, Brazil, and South America, we work hard to bring best practices and a pragmatic perspective to every customer’s implementation of their solutions.

If you like what you are reading, please share this newsletter with your colleagues so they can enjoy the same valuable information.